[HTML][HTML] Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy

Y Yu, J Yu, S Ge, Y Su, X Fan - International Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Currently, cancer treatment mainly consists of surgery, radiotherapy, chemotherapy,
immunotherapy, and molecular targeted therapy, of which radiotherapy is one of the major …

Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis

JRD Arundhathi, SR Mathur, A Gogia, SVS Deo… - Molecular Biology …, 2021 - Springer
Among breast cancer subtypes, the triple negative breast cancer (TNBC) has the worst
prognosis. In absence of any permitted targeted therapy, standard chemotherapy is the …

Targeting pyruvate kinase M2 phosphorylation reverses aggressive cancer phenotypes

M Apostolidi, IA Vathiotis, V Muthusamy, P Gaule… - Cancer research, 2021 - AACR
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype with low
survival rate and a lack of biomarkers and targeted treatments. Here, we target pyruvate …

GTP signaling links metabolism, DNA repair, and responses to genotoxic stress

W Zhou, Z Zhao, A Lin, JZ Yang, J Xu… - Cancer discovery, 2024 - AACR
How cell metabolism regulates DNA repair is incompletely understood. Here, we define a
GTP-mediated signaling cascade that links metabolism to DNA repair and has significant …

Radiosensitizing pancreatic cancer via effective autophagy inhibition

T Yazal, J Bailleul, Y Ruan, D Sung, FI Chu… - Molecular cancer …, 2022 - AACR
Despite aggressive treatments, pancreatic ductal adenocarcinoma (PDAC) remains an
intractable disease, largely because it is refractory to therapeutic interventions. To overcome …

[HTML][HTML] Metabolic-Modulating Effects of Radiation: Undetectable Yet Deadly—A Review on Radiotherapy

F Fiorica, U Tebano, G Napoli, A Franceschetto… - …, 2024 - pmc.ncbi.nlm.nih.gov
Simple Summary This review explores how radiotherapy disrupts critical metabolic
pathways in cancer cells. It highlights vulnerabilities in glucose metabolism, lipid synthesis …

M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance

J Bailleul, Y Ruan, L Abdulrahman, AJ Scott… - Neuro …, 2023 - academic.oup.com
Background Resistance to existing therapies is a significant challenge in improving
outcomes for glioblastoma (GBM) patients. Metabolic plasticity has emerged as an important …

Metabolic response to radiation therapy in cancer

GH Read, J Bailleul, E Vlashi… - Molecular …, 2022 - Wiley Online Library
Tumor metabolism has emerged as a hallmark of cancer and is involved in carcinogenesis
and tumor growth. Reprogramming of tumor metabolism is necessary for cancer cells to …

Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice

Q Jin, X Zhou, X Niu, C Ping, X Dong, D Duan… - Colloids and Surfaces B …, 2024 - Elsevier
In order to reduce the cardiotoxicity of doxorubicin (DOX) and improve its antitumor effect,
dihydroartemisinin (DHA) and DOX prodrug (DOX-S-DHA) synthesized via a single sulfur …

[HTML][HTML] Modulating the radiation response for improved outcomes in breast cancer

AM Pesch, LJ Pierce, CW Speers - JCO Precision Oncology, 2021 - ncbi.nlm.nih.gov
Radiation therapy (RT) is an effective therapeutic modality in breast cancer used as part of
the standard of care to prevent locoregional recurrences and distant metastases …